![Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights](https://f6publishing.blob.core.windows.net/58a33c97-ccc4-49ba-b806-a0d4dfa3f930/WJH-7-1834-g002.jpg)
Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights
![BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA - ScienceDirect BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827819307184-fx1.jpg)
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA - ScienceDirect
![Serum VEGF as a Tumor Marker in Patients with HCV-related Liver Cirrhosis and Hepatocellular Carcinoma | Anticancer Research Serum VEGF as a Tumor Marker in Patients with HCV-related Liver Cirrhosis and Hepatocellular Carcinoma | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/33/3/1013/F1.large.jpg)
Serum VEGF as a Tumor Marker in Patients with HCV-related Liver Cirrhosis and Hepatocellular Carcinoma | Anticancer Research
![Circulating biomarkers for early detection of hepatocellular carcinoma - Boris J. B. Beudeker, Andre Boonstra, 2020 Circulating biomarkers for early detection of hepatocellular carcinoma - Boris J. B. Beudeker, Andre Boonstra, 2020](https://journals.sagepub.com/cms/10.1177/1756284820931734/asset/images/large/10.1177_1756284820931734-fig1.jpeg)
Circulating biomarkers for early detection of hepatocellular carcinoma - Boris J. B. Beudeker, Andre Boonstra, 2020
![Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know](https://pub.mdpi-res.com/cancers/cancers-14-01493/article_deploy/html/images/cancers-14-01493-g001.png?1647332793)
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
![Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma - Galle - 2019 - Liver International - Wiley Online Library Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma - Galle - 2019 - Liver International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3d295f89-2cbe-4b75-ade6-fa2c33e2cb03/liv14223-fig-0003-m.jpg)
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma - Galle - 2019 - Liver International - Wiley Online Library
Osteopontin as a Tumor Marker for Hepatocellular Carcinoma | Mohamed | Journal of Gastroenterology and Hepatology Research
![Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know](https://pub.mdpi-res.com/cancers/cancers-14-01493/article_deploy/html/images/cancers-14-01493-g002.png?1647332793)
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
![Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S001650851936771X-fx1.jpg)